Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma.
J Immunol Res
; 2022: 6521290, 2022.
Article
in En
| MEDLINE
| ID: mdl-35677538
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma of Lung
/
Lung Neoplasms
/
Neoplastic Cells, Circulating
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Immunol Res
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: